文献速递冠心病血脂与心血管预防

稳定性冠心病功能学检查与冠状动脉CT血管造影的比较

Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该丹麦全国注册研究纳入2009至2015年86,705例稳定疑似冠心病门诊患者,比较初始功能学检查与冠状动脉CT血管造影(CTA)对后续用药、侵入性操作及临床结局的影响。冠状动脉CTA组他汀、阿司匹林、侵入性冠状动脉造影和经皮冠状动脉介入使用率及费用更高,校正后全因死亡风险相当(HR 0.96;95%CI 0.88-1.05),心肌梗死风险更低(HR 0.71;95%CI 0.61-0.82)。

要点

  • 冠状动脉CTA组他汀(15.9% vs 9.1%)、阿司匹林(12.7% vs 8.5%)、侵入性冠状动脉造影(14.7% vs 10.1%)和经皮冠状动脉介入(3.8% vs 2.1%)使用率均高于功能学检查组,所有p<0.001。
  • 冠状动脉CTA组后续检查、侵入性操作和药物平均费用高于功能学检查组(995美元 vs 718美元;p<0.001)。
  • 校正后冠状动脉CTA与全因死亡风险相当(HR 0.96;95%CI 0.88-1.05),心肌梗死风险更低(HR 0.71;95%CI 0.61-0.82)。

核心结论

  • 在稳定疑似冠心病患者初始评估中,冠状动脉CTA与功能学检查相比,他汀、阿司匹林和侵入性操作使用更多、费用更高,心肌梗死风险更低但全因死亡风险相似。

研究设计与样本

  • 丹麦全国注册研究,纳入2009至2015年接受初始无创心脏检查(冠状动脉CTA或功能学检查:运动心电图或核素负荷试验)的稳定症状门诊患者86,705例,功能学检查组53,744例(平均年龄57.4岁,49%男性),冠状动脉CTA组32,961例(平均年龄57.4岁,45%男性),中位随访3.6年。

主要发现

  • 冠状动脉CTA组他汀使用率15.9% vs 功能学检查组9.1%,阿司匹林12.7% vs 8.5%,侵入性冠状动脉造影14.7% vs 10.1%,经皮冠状动脉介入3.8% vs 2.1%,所有p<0.001。
  • 冠状动脉CTA组后续检查、侵入性操作和药物平均费用995美元 vs 功能学检查组718美元(p<0.001)。
  • 未校正死亡率冠状动脉CTA组2.1% vs 功能学检查组4.0%,心肌梗死住院率0.8% vs 1.5%(均p<0.001)。
  • 校正后冠状动脉CTA与全因死亡风险相当(HR 0.96;95%CI 0.88-1.05),心肌梗死风险更低(HR 0.71;95%CI 0.61-0.82)。

关键数值与推荐

  • 冠状动脉CTA组他汀使用率15.9% vs 功能学检查组9.1%(p<0.001)。
  • 冠状动脉CTA组阿司匹林使用率12.7% vs 功能学检查组8.5%(p<0.001)。
  • 冠状动脉CTA组侵入性冠状动脉造影使用率14.7% vs 功能学检查组10.1%(p<0.001)。
  • 冠状动脉CTA组经皮冠状动脉介入使用率3.8% vs 功能学检查组2.1%(p<0.001)。
  • 冠状动脉CTA组平均费用995美元 vs 功能学检查组718美元(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The choice of either anatomical or functional noninvasive testing to evaluate suspected coronary artery disease might affect subsequent clinical management and outcomes. OBJECTIVES: This study analyzed the association of initial noninvasive cardiac testing in outpatients with stable symptoms, with subsequent use of medications, invasive procedures, and clinical outcomes. METHODS: We studied patients enrolled in a Danish nationwide register who underwent initial noninvasive cardiac testing with either coronary computed tomography angiography (CTA) or functional testing (exercise electrocardiography or nuclear stress testing) from 2009 to 2015. Further use of noninvasive testing, invasive procedures, medications, and medical costs within 120 days were evaluated. Risks of long-term mortality and myocardial infarction (MI) were analyzed using adjusted Cox proportional hazard models. RESULTS: A total of 86,705 patients underwent either functional testing (n = 53,744, mean age 57.4 years, 49% males) or coronary CTA (n = 32,961, mean age 57.4 years, 45% males), and were followed for a median of 3.6 years. Compared with functional testing, there was significantly higher use of statins (15.9% vs. 9.1%), aspirin (12.7% vs. 8.5%), invasive coronary angiography (14.7% vs. 10.1%), and percutaneous coronary intervention (3.8% vs. 2.1%); all p < 0.001 after coronary CTA. The mean costs of subsequent testing, invasive procedures, and medications were higher after coronary CTA ($995 vs. $718; p < 0.001). Unadjusted rates of mortality (2.1% vs. 4.0%) and MI hospitalization (0.8% vs. 1.5%) were lower after coronary CTA than functional testing (both p < 0.001). After adjustment, coronary CTA was associated with a comparable all-cause mortality (hazard ratio: 0.96; 95% confidence interval: 0.88 to 1.05), and a lower risk of MI (hazard ratio: 0.71; 95% confidence interval: 0.61 to 0.82). CONCLUSIONS: In stable patients undergoing initial evaluation for suspected coronary artery disease, coronary CTA was associated with greater use of statins, aspirin, and invasive procedures, and higher costs than functional testing. Coronary CTA was associated with a lower risk of MI, but a similar risk of all-cause mortality.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Jørgensen ME, Andersson C, Nørgaard BL, et al. Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease. J Am Coll Cardiol. 2017. PMID: 28385304. doi:10.1016/j.jacc.2017.01.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。